AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
P
PureTechPureTech Health is a publicly traded biopharmaceutical company that discovers, develops, and commercializes breakthrough medicines by founding and funding a network of subsidiary companies, including Celea Therapeutics.
2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
2005
Irvine, California
HQ
Boston, Massachusetts
Public (AEON)
Status
Public (PRTC)
AEON Biopharma investors
No investors on record.
PureTech investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and PureTech.